Elaine Schuessler, NP

Concierge Medicine NP | IR NP | MedTech Development | Translational Science Expert

[Elaine Schuessler, NP @TexasNP]

Can't wait to see you there!!

[HistoSonics, Inc. @histosonics]

HistoSonics, Inc. is ready to connect with you at #IHPBA in Singapore on October 28-31st. Join us for a Lunch Symposium on Thursday, Oct 29 and stop by booth #F06 for an Innovation Session on Friday, Oct 30 from 9:30-10:00 to learn more about the Edison #Histotripsy System.

[HistoSonics, Inc. @histosonics]

@HistoSonics just concluded this year’s #HistotripsySummit in Phoenix, AZ. This annual gathering brought together over 300 attendees from across the growing, multidisciplinary #histotripsy community to advance patient care.

[HistoSonics, Inc. @histosonics]

📢Just a few days away! If you're heading to #CIRSE2026 in Copenhagen, connect with the HistoSonics team and add these two events to your schedule on Monday, September 7th.

[HistoSonics, Inc. @histosonics]

Join us! Register for a Live Webinar – #Histotripsy for Liver Tumors: Current Experience and Considerations for Medical Oncologists
🗓️ Thursday, September 24th
🕔 5:00 PM CT / 6:00 PM ET
https://t.co/ruXMAAGR7e

[HistoSonics, Inc. @histosonics]

HistoSonics announces the opening of its expanded Histotripsy Training Center in Hong Kong, reinforcing the city's position as a leading hub for physician education, clinical collaboration, and innovation in Asia.
https://t.co/L7nZruy0Db #histosonics #histotripsy

[HistoSonics, Inc. @histosonics]

HistoSonics has received CE Mark approval in Europe for its Edison® System, enabling commercialization of the company’s non-invasive histotripsy technology in Europe and other markets that recognize the CE Mark. https://t.co/rOwIY97aEz

[HistoSonics, Inc. @histosonics]

At HistoSonics, our mission is to deliver #NewHope to patients who need it most. Julie’s story is one of resilience and serves as a powerful reminder of the impact #histotripsy can have by expanding treatment options for patients around the world. https://t.co/P2j9Ayeijf

[Elaine Schuessler, NP @TexasNP]

"Stronger Together!" 🤝 Incredible discussions are happening now on immunotherapy combination strategies as we head into Day 3, the final day of #ASCOBT26. 🔬💊
What has been your biggest takeaway so far? 👇💭

[Elaine Schuessler, NP @TexasNP]

Prognostic ≠ Utility! 🛑 Excellent insights from Dr. Jeanne Tie at #ASCOBT26 on moving MRD/ctDNA to actionable clinical utility. We need:

>Level 1 evidence (like DYNAMIC & IMvigor011) 📊

>Proof that acting on MRD improves care 🩺

>Context-appropriate trials 🔬

[Elaine Schuessler, NP @TexasNP]

The #ASCOBT26 meeting continues today with additional exceptional discussions. #futureofmedicine #precisionmedicine #ASCO

[HistoSonics, Inc. @histosonics]

HistoSonics is honored to announce a new financing round with participation from Yosemite, alongside several strategic investors who share our commitment to advancing non-invasive histotripsy. https://t.co/UBZdIMS1UQ

[Elaine Schuessler, NP @TexasNP]

Connect with leading voices in vascular care at the BD Advance Peripheral Vascular Summit, Jan 22–23 in Scottsdale. Collaborate, learn & advance patient outcomes. Space is limited— contact us now! #BDemployee https://t.co/rdy7chVeFN

[Elaine Schuessler, NP @TexasNP]

My PIVO™ Story: Taylor and Fred's Clinician and Patient Portrait #BDemployee https://t.co/cpxsyEZ1wW

[Elaine Schuessler, NP @TexasNP]

Connect with leading voices in vascular care at the BD Advance Peripheral Vascular Summit, Jan 22–23 in Scottsdale. Collaborate, learn & advance patient outcomes. Space is limited— contact us now! #BDemployee https://t.co/PKwIISHqFr

[Elaine Schuessler, NP @TexasNP]

Connect with leading voices in vascular care at the BD Advance Peripheral Vascular Summit, Jan 22–23 in Scottsdale. Collaborate, learn & advance patient outcomes. Space is limited— contact us now! #BDemployee https://t.co/7RYOIU1ukl

[Elaine Schuessler, NP @TexasNP]

An impressive lineup. The BD Breast Tissue Marker portfolio offers 14 shapes across five materials. Check out our latest shapes: https://t.co/cqLBNn9kCv #breastcancerawareness #breastbiopsy #BDemployee https://t.co/U7Dqustfes

[Elaine Schuessler, NP @TexasNP]

Join us Jan 22–23 in Scottsdale for the BD Advance Peripheral Vascular Summit! Two days of expert insights, hands-on learning & networking. Limited spots—contact us now! #BDemployee https://t.co/pKhQf9oyHq

[Elaine Schuessler, NP @TexasNP]

American Cancer Society now recommends self-collection of HPV samples #BDemployee https://t.co/HECy13pSF7

[Elaine Schuessler, NP @TexasNP]

Discover the latest in arterial & venous care at the BD Advance Peripheral Vascular Summit, Jan 22–23 in Scottsdale. Learn from top experts & explore cutting-edge tech. Express your interest today! #BDemployee https://t.co/40H4LFEYDp

[Elaine Schuessler, NP @TexasNP]

Thrilled to see BD partnering with ChemoGLO™! This collaboration combines rapid results and deeper insights to help reduce hazardous drug exposure risks for health care workers. Details here: #BDemployee https://t.co/lqSXGWnxPq